Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 195 | 1 | 210 | +16 |
| Shares | 155.8M | 20.3K | 157.8M | +2.01M (+1.3%) |
| Value | $6.61B | $861.0K | $6.67B | +$64.2M (+1.0%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (29)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (1)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Kellner Capital, LLC | 20,300 | $861.0K |